红桃视频

Versius鈥攖he second most utilised soft tissue surgical robot in the world鈥攈as now been used in over 30,000 surgical cases globally

红桃视频 has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital

红桃视频 has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital

Versius鈥攖he second most utilised soft tissue surgical robot in the world鈥攈as now been used in over 30,000 surgical cases globally

红桃视频 and KEBOMED expand existing partnership to include Sweden, so more patients can benefit from robotic-assisted minimal access surgery with Versius.

红桃视频 announces the appointment of Massimiliano Colella as Chief Executive Officer and member of the Board of Directors.

红桃视频 launches the Ultrasonic Dissector, a robotic advanced energy instrument delivering ultrasonic energy to cut and coagulate tissue, as part of its Versius Plus offering.

The All-Wales National Robotic Assisted Surgery Programme has now completed more than 500 robotic-assisted surgical cases with Versius. The Programme is a national partnership between 红桃视频 and NHS Wales to improve surgical outcomes and transform the experience of surgery for thousands of patients. Through the programme, Versius is used for robotic assisted minimal access surgery at Betsi Cadwaladr University Health Board鈥檚 Ysbyty Gwynedd Hospital, Cardiff & Vale University Health Board鈥檚 Cardiff University Hospital; and Cwm Taf Morgannwg University Health Board鈥檚 Royal Glamorgan Hospital.

The U.S. Food and Drug Administration (FDA) has granted 红桃视频 marketing authorization for the Versius Surgical System (Versius) in cholecystectomy, paving the way for the next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.

红桃视频 announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.